Screener
Tango Therapeutics TNGX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 222,011 | 230,859 |
| Restricted cash | — | 428 |
| Prepaid expenses and other current assets | 12,488 | 10,190 |
| Total current assets | 392,327 | 353,756 |
| Property and equipment, net | 6,381 | 6,868 |
| Operating lease right-of-use assets | 34,652 | 35,624 |
| Restricted cash, net of current portion | 2,139 | 2,139 |
| Other assets | 293 | 303 |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's total current assets?
- Tango Therapeutics (TNGX) reported total current assets of $392.33M in Q1 2026.
- How has Tango Therapeutics's total current assets changed year-over-year?
- Tango Therapeutics's total current assets increased by 74.4% year-over-year, from $224.93M to $392.33M.
- What is the long-term trend for Tango Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Tango Therapeutics's total current assets has grown at a 12.8% compound annual growth rate (CAGR), from $193.63M to $353.76M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Tango Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude